Strategy Leader, Infectious Diseases, Medicines Discovery Catapult, and Director of PACE Antimicrobial resistance (AMR) is not a future problem; it is unfolding now. In 2019, almost five million ...

A health care company that previously announced big plans for expansion and hiring at its Birmingham headquarters is now shutting down. Pack Health, which was founded in Birmingham in 2013 and later ...

A second community diagnostics centre is being planned for the centre of Plymouth. University Hospitals Plymouth NHS Trust said it was "working on a business case" for another centre, similar to the ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc.

Epic will provide software to Quest Diagnostics under a new deal to improve digital connectivity with health systems and other providers. The EHR company, which has been expanding its laboratory ...

Figure 1 depicts the ways in which implicit bias (including stereotypes) that leads to false assumptions about an individual patient, combined with inattention to systemic and structural factors ...

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

AST Revolution, LLC (AST Revolution) today announced its official launch following the recent completion of a court-approved acquisition of select assets of Accelerate Diagnostics, Inc. (Accelerate) ...

--Siemens Healthineers has been in exploratory talks with private-equity firms including Blackstone, CVC Capital Partners and KKR about a potential sale of its diagnostics unit, Bloomberg reports, ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...

As the “Swiss Army knife of bacteria,” methicillin-resistant Staphylococcus aureus is quite the problematic organism, said John Osiecki, PhD. Among the diverse group of gram-positive bacteria ...